Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) FCF Margin (2016 - 2025)

Immucell (ICCC) has disclosed FCF Margin for 16 consecutive years, with 32.26% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin fell 1897.0% year-over-year to 32.26%, compared with a TTM value of 2.58% through Sep 2025, up 1543.0%, and an annual FY2024 reading of 0.41%, up 3718.0% over the prior year.
  • FCF Margin was 32.26% for Q3 2025 at Immucell, down from 22.44% in the prior quarter.
  • Across five years, FCF Margin topped out at 22.44% in Q2 2025 and bottomed at 99.93% in Q1 2023.
  • Average FCF Margin over 5 years is 16.13%, with a median of 5.68% recorded in 2021.
  • The sharpest move saw FCF Margin tumbled -9711bps in 2023, then soared 10473bps in 2024.
  • Year by year, FCF Margin stood at 2.14% in 2021, then tumbled by -3225bps to 71.29% in 2022, then soared by 120bps to 14.23% in 2023, then crashed by -118bps to 2.57% in 2024, then tumbled by -1155bps to 32.26% in 2025.
  • Business Quant data shows FCF Margin for ICCC at 32.26% in Q3 2025, 22.44% in Q2 2025, and 15.43% in Q1 2025.